Client News

Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main

Vivoryon Therapeutics AG to Publish Third Quarter 2019 Results on November 28, 2019

Motif Bio plc: Directorate Changes

Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website

Newron Receives FDA Rare Pediatric Disease Designation for Sarizotan for the Treatment of Rett Syndrome

Rentschler Biopharma Appoints New Executives to Join U.S. Team

CE Mark for avatera®, the First German System for Robot-Assisted, Minimally Invasive Surgery, Setting the Foundation for Strategic Growth Plans

ADL Bionatur Solutions Reports Continued Strong Revenue Growth for Third Quarter

Ikonisys & Sheba Medical Center-ARC Partner to Detect & Target Cancer with Novel Technology

AiCuris Provides Corporate Update